Stocks and InvestingStocks and Investing
Mon, July 11, 2022
Sun, July 10, 2022
Fri, July 8, 2022
Thu, July 7, 2022
Wed, July 6, 2022

William Maughan Initiated (BNTX) at Strong Buy and Held Target at $192 on, Jul 6th, 2022


Published on 2024-10-27 21:46:12 - WOPRAI, William Maughan
  Print publication without navigation


William Maughan of Canaccord Genuity, Initiated "BioNTech SE" (BNTX) at Strong Buy and Held Target at $192 on, Jul 6th, 2022.

William has made no other calls on BNTX in the last 4 months.



There are 5 other peers that have a rating on BNTX. Out of the 5 peers that are also analyzing BNTX, 3 agree with William's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Emmanuel Papadakis of "Deutsche Bank" Maintained at Hold and Held Target at $180 on, Wednesday, June 1st, 2022
  • Chris Shibutani of "Goldman Sachs" Maintained at Hold with Decreased Target to $206 on, Tuesday, May 24th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $195 on, Tuesday, May 10th, 2022


These are the ratings of the 2 analyists that currently disagree with William


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $298 on, Tuesday, April 12th, 2022
  • Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $300 on, Tuesday, April 5th, 2022